Epidemiological profile of inflammatory bowel disease in Caxias do Sul, Brazil

a cross-sectional study

Authors

Keywords:

Inflammatory bowel disease, Crohn disease, Colitis, ulcerative, Infliximab, Adalimumab

Abstract

BACKGROUND: Inflammatory bowel diseases affect mostly young patients and have a huge impact on their quality of life and growing treatment costs. Currently, there are few Brazilian studies concerning their epidemiological profile. OBJECTIVE: The aim of this study was to describe the regional clinical and epidemiological profile of these pathological conditions in Caxias do Sul, Brazil. DESIGN AND SETTING: Cross-sectional study in Caxias do Sul (RS), Brazil. METHODS: A search for patients was conducted in the municipality’s special medications pharmacy using the International Classification of Diseases, and medical records were manually reviewed for data collec- tion. Sixty-seven patients were included. RESULTS: The patients’ mean age was 46.5 years and females predominated (71.6%). Ulcerative colitis was the most prevalent disease (70%) and Montreal E3 was the most prevalent presentation. The mean age at diagnosis was 39 years. Most patients had recently undergone colonoscopy (67%). Only five patients (7.4%) had records of hospital admission due to the disease, while 12 (18%) underwent a surgical proce- dure during follow-up. Sixty patients (89.5%) were using aminosalicylates, while less than one fifth were using immunosuppressants or immunobiological drugs: 19.4% and 14.9%, respectively. CONCLUSION: The profile of inflammatory bowel disease patients in this region of Brazil is similar in some characteristics to other published Brazilian data, although it differs in others such as higher frequency of pan- colitis. A prospective study on these patients is planned in this region, in order to improve the data quality.

Downloads

Download data is not yet available.

Author Biographies

Vincent Marin Dall’Oglio, Department of Clinical Gastroenterology, Universidade de Caxias do Sul

MD. Resident, Department of Internal Medicine, Hospital Geral de Caxias do Sul, Caxias do Sul (RS), Brazil; Resident, Department of Gastroenterology, Hospital de Clínicas de Porto Alegre, Porto Alegre (RS), Brazil.

Rafael Sartori Balbinot, Department of Clinical Gastroenterology, Universidade de Caxias do Sul

MD. Physician, School of Medicine, Universidade de Caxias do Sul (UCS), Caxias do Sul (RS), Brazil; Resident, Department of Internal Medicine, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre (RS), Brazil.

Ana Laura Facco Muscope, Department of Clinical Gastroenterology, Universidade de Caxias do Sul

MD. Physician, School of Medicine, Universidade de Caxias do Sul (UCS), Caxias do Sul (RS), Brazil.

Mateus Dal Castel, Department of Clinical Gastroenterology, Universidade de Caxias do Sul

MD. Physician, School of Medicine, Universidade de Caxias do Sul (UCS), Caxias do Sul (RS), Brazil.

Thianan Ricardo Souza, Department of Clinical Gastroenterology, Universidade de Caxias do Sul

MD. Physician, School of Medicine, Universidade de Caxias do Sul (UCS), Caxias do Sul (RS), Brazil; Resident, Department of Pediatrics, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre (RS), Brazil.

Renan Souza de Macedo, Department of Clinical Gastroenterology, Universidade de Caxias do Sul

MD. Physician, School of Medicine, Universidade de Caxias do Sul (UCS), Caxias do Sul (RS), Brazil

Thanize Barbosa de Oliveira, Department of Clinical Gastroenterology, Universidade de Caxias do Sul

MD. Physician, School of Medicine, Universidade de Caxias do Sul (UCS), Caxias do Sul (RS), Brazil.

Raul Angelo Balbinot, Department of Clinical Gastroenterology, Universidade de Caxias do Sul

MD, MSc, PhD. Titular Professor, Department of Clinical Gastroenterology, School of Medicine, Universidade de Caxias do Sul (UCS), Caxias do Sul (RS), Brazil.

Silvana Sartori Balbinot, Department of Clinical Gastroenterology, Universidade de Caxias do Sul

MD, PhD. Titular Professor, Department of Clinical Gastroenterology, School of Medicine, Universidade de Caxias do Sul (UCS), Caxias do Sul (RS), Brazil.

Eduardo Brambilla, Department of Clinical Gastroenterology, Universidade de Caxias do Sul

MD, MSc. Proctologist and Associate Professor, Department of Clinical Gastroenterology, School of Medicine, Universidade de Caxias do Sul (UCS), Caxias do Sul (RS), Brazil; Associate Member, Grupo de Estudos da Doença Inflamatória Intestinal do Brasil (GEDIIB), São Paulo (SP), Brazil.

Jonathan Soldera, Department of Clinical Gastroenterology, Universidade de Caxias do Sul

MD, MSc. Associate Professor, Department of Clinical Gastroenterology, School of Medicine, Universidade de Caxias do Sul (UCS), Caxias do Sul (RS), Brazil; Doctoral Student: Pathology, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre (RS), Brazil; Associate Member, Grupo de Estudos da Doença Inflamatória Intestinal do Brasil (GEDIIB), São Paulo (SP), Brazil.

References

Barros PAC, Silva AMR, Neto MADFL. The epidemiological profile of inflammatory bowel disease patients on biologic therapy at a public hospital in Alagoas. J Coloproctol. 2014;34(3):131-5. doi: 10.1016/j. jcol.2014.05.004.

Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology. 2004;126(6):1504-17. PMID: 15168363; doi: 10.1053/j. gastro.2004.01.063.

Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142(1):46-54. PMID: 22001864; doi: 10.1053/j.gastro.2011.10.001.

Zaltman C. Doença inflamatória intestinal: qual a relevância da doença no Brasil? Cad Saude Publica. 2007;23(5):992-3. doi: 10.1590/S0102-311X2007000500001.

Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl. 1989;170:2-19. PMID: 2617184; doi: 10.3109/00365528909091339.

Schirbel A, Fiocchi C. Inflammatory bowel disease: Established and evolving considerations on its etiopathogenesis and therapy. J Dig Dis. 2010:11(5):266-76. PMID: 20883422; doi: 10.1111/j.1751-2980.2010.00449.x.

Souza MH, Troncon LE, Rodrigues CM, et al. Evolução da ocorrência (1980-1999) da doença de Crohn e da retocolite ulcerativa idiopática e análise das suas características clínicas em um hospital universitário do sudeste do Brasil [Trends in the occurrence (1980-1999) and clinical features of Crohn’s disease and ulcerative colitis in a university hospital in southeastern Brazil]. Arq Gastroenterol. 2002;39(2):98-105. PMID: 12612713; doi: 10.1590/s0004-28032002000200006.

Souza MM, Belasco AGS, Aguilar-Nascimento JE. Perfil epidemiológico dos pacientes portadores de doença inflamatória intestinal do estado de Mato Grosso [The epidemiological profile of patients with inflammatory Bowel disease in the State of Mato Grosso]. Rev Bras Colo-Proctol. 2008;28(3):324-8. doi: 10.1590/S0101-98802008000300009.

Kleinubing-Júnior H, Pinho MSL, Ferreira LC, Bachtold GA, Merki A. Perfil dos pacientes ambulatoriais com doenças inflamatórias intestinais [Outpatients profile with inflammatory bowel disease]. ABCD Arq Bras Cir Dig. 2011;24(3):200-3. doi: 10.1590/S0102-67202011000300004.

Thukkani N, Williams JL, Sonnenberg A. Epidemiologic characteristics of patients with inflammatory bowel disease undergoing colonoscopy. Inflamm Bowel Dis. 2011;17(6):1333-7. PMID: 21560196; doi: 10.1002/ibd.21513.

Munkholm P, Langholz E, Nielsen OH, Kreiner S, Binder V. Incidence and prevalence of Crohn’s disease in the county of Copenhagen, 1962-87: a sixfold increase in incidence. Scand J Gastroenterol. 1992;27(7):609-14. PMID: 1641589; doi: 10.3109/00365529209000127.

Loftus EV Jr, Silverstein M, Sandborn WJ, et al. Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gut. 2000;46(3):336-43. PMID: 10673294; doi: 10.1136/gut.46.3.336.

Ekbom A, Helmick C, Zack M, Adami HO. The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology. 1991;100(2):350-8. PMID: 1985033; doi: 10.1016/0016-5085(91)90202-v.

Kotze PG, Underwood FE, Damião AOMC, et al. Progression of Inflammatory Bowel Diseases Throughout Latin America and the Caribbean: A Systematic Review. Clin Gastroenterol Hepatol. 2020;18(2):304-12. PMID: 31252191; doi: 10.1016/j.cgh.2019.06.030.

Terres AZ, Furlan RG, Soldera J, Balbinot SS, Balbinot RA. Clinical and surgical therapy for fistulizing Crohn’s disease: case report. GED Gastroenterol Endosc Dig. 2019:38(1):27-32

Shinagawa T, Hata K, Ikeuchi H, et al. Rate of Reoperation Decreased Significantly After Year 2002 in Patients With Crohn’s Disease. Clin Gastroenterol Hepatol. 2020;18(4):898-907. PMID: 31336198; doi: 10.1016/j.cgh.2019.07.025.

Downloads

Published

2020-12-03

How to Cite

1.
Dall’Oglio VM, Balbinot RS, Muscope ALF, Castel MD, Souza TR, Macedo RS de, Oliveira TB de, Balbinot RA, Balbinot SS, Brambilla E, Soldera J. Epidemiological profile of inflammatory bowel disease in Caxias do Sul, Brazil: a cross-sectional study. Sao Paulo Med J [Internet]. 2020 Dec. 3 [cited 2025 Oct. 16];138(6):530-6. Available from: https://periodicosapm.emnuvens.com.br/spmj/article/view/373

Issue

Vol. 138 No. 6 (2020)

Section

Original Article

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.